BioNano Genomics Launches Irys In Europe At ESHG 2013

June 7, 2013

BioNano Genomics demonstrated the first de novo human genome mapping on Irys System and officially launched in Europe at European Society of Human Genetics (ESHG). BioNano also appointed Dr. Fahim Amini as vice president, Commercial Operations EMEA.
More »

Preclinical and Phase 1 Data of VTX-2337 Presented at 2013 ASCO Annual Meeting Shows Early Activity in Ovarian Cancer

June 3, 2013

At ASCO, VentiRx presented positive preclinical and clinical data of VTX-2337, a toll-like receptor 8 agonist (TLR-8), in combination with Doxil® (pegylated liposomal doxorubicin) or paclitaxel in women with recurrent ovarian cancer.
More »

Celator® Pharmaceuticals Announces New Data On Factors Associated With Outcomes In AML Patients Treated With CPX-351

June 3, 2013

Celator presented data at ASCO from two randomized Phase 2 studies of CPX-351 in patients with acute myeloid leukemia (AML) which has confirmed the consistent activity of CPX-351 and identified several prognostic factors for outcomes in the studies.
More »